Publiziert in: Marktpuls, Unternehmen
Frei

10% OF STRAUMANN’S SHARES CHANGE OWNERSHIP Montag, 26. November 2012 - 07:33

10% OF STRAUMANN’S SHARES CHANGE OWNERSHIP

Basel, Switzerland – 26 November 2012: Straumann Holding AG has been informed by two of its existing shareholders about a transaction involving a 10% block of registered shares. Dr h.c. Thomas Straumann, who is the major shareholder and Vice Chairman of the Board, has sold the shares to the Government of Singapore Investment Corporation Pte. Ltd. (GIC), bringing the two parties’ respective stakes to 17% and 14% of the total share capital of Straumann Holding AG.

Thomas Straumann commented: “The prevailing weak economic environment has made it necessary to reallocate funds in order to support and meet my investment commitments in other areas. My belief in the long-term future of Straumann is undiminished, and I have every confidence in its business fundamentals, people, and strategy. Straumann remains my core investment, and I fully intend to continue contributing to its direction as a principal shareholder for the long-term.”

In addition, Dr Straumann has agreed to a one-year lock-up period, during which he will not reduce his stake.

GIC has also expressed its long-term shareholder interest in the company. GIC was established in 1981 and is one of the world’s leading sovereign wealth funds. Its aim is to achieve good long-term returns for its owner, the Government of Singapore.

About Straumann

Headquartered in Basel, Switzerland, the Straumann Group (SIX: STMN) is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs 2575 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland.

Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01

E-mail: investor.relations@straumann.com or corporate.communication@straumann.com

Homepage: www.straumann.com

Contacts:

Investor Relations:

Fabian Hildbrand

+41 (0)61 965 13 27

Corporate Communication:

Mark Hill

+41 (0)61 965 13 21

Thomas Konrad

+41 (0)61 965 15 46

Details on upcoming investor relations activities are published on www.straumann.com (Investors > Events).

Straumann Media Releases subscription:

www.straumann.com/en/home/investor-relations/ir-contacts-and-services/subscription.html

RSS feed subscription:

http://xml.newsbox.ch/corporate_web/che/straumann/press_release/digest_complete_de_press_release_atom.xml

Disclaimer

This release contains certain forward-looking statements, which can be identified by the use of terminology such as ‘to support’, ‘to meet‘, ‘future’, ‘remain’, ‘continue’, ‘aim’, or similar wording. Such forward-looking statements reflect the current views of management and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Group to differ materially from those expressed or implied. These include risks related to the success of and demand for the Group’s products, the potential for the Group’s products to become obsolete, the Group’s ability to defend its intellectual property, the Group’s ability to develop and commercialize new products in a timely manner, the dynamic and competitive environment in which the Group operates, the regulatory environment, changes in currency exchange rates, the Group’s ability to hire and retain key talented individuals, to generate revenues and profitability, to realize its expansion projects in a timely manner, and to maintain its business relationships with suppliers, customers and other third parties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this report. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in it as a result of new information, future events or otherwise.

#  #  #